Op-Ed: Drug Regulation: The Worst Has Become the Norm

September 26, 2007

The pendulum swings back and forth about what ails the regulation of drug development. Thirty years ago, the concerns were primarily about “drug lag” – indolent reviews and approvals by the FDA that put Americans at disadvantage to consumers in other countries. In recent years, however, there have been repeated accusations about what might be called “drug leap” – a supposedly “too cozy” relationship between regulators and industry, along with too little attention paid to drug safety, possibly as the result of regulators’ pressing to meet arbitrary deadlines. (TCS Daily)